MEPOLIZUMAB — all Canadian products
4 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is MEPOLIZUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02492989 | NUCALA | GLAXOSMITHKLINE INC | Solution | Subcutaneous | MEPOLIZUMAB 100 MG | Marketed | |
| 02492997 | NUCALA | GLAXOSMITHKLINE INC | Solution | Subcutaneous | MEPOLIZUMAB 100 MG | Marketed | |
| 02530821 | NUCALA | GLAXOSMITHKLINE INC | Solution | Subcutaneous | MEPOLIZUMAB 40 MG | Marketed | |
| 02449781 | NUCALA | GLAXOSMITHKLINE INC | Powder For Solution | Subcutaneous | MEPOLIZUMAB 100 MG | Cancelled Post Market |
Browse other molecules: